Form 8-K - Current report:
SEC Accession No. 0001193125-25-122511
Filing Date
2025-05-19
Accepted
2025-05-19 16:56:17
Documents
13
Period of Report
2025-05-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d939029d8k.htm   iXBRL 8-K 24583
2 EX-99.1 d939029dex991.htm EX-99.1 28731
  Complete submission text file 0001193125-25-122511.txt   176027

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tecx-20250517.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tecx-20250517_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tecx-20250517_pre.xml EX-101.PRE 11268
15 EXTRACTED XBRL INSTANCE DOCUMENT d939029d8k_htm.xml XML 3639
Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Filer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 25964828
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)